» Articles » PMID: 15030574

A Recombinant Vaccinia Virus Encoding the Interferon-inducible T-cell Alpha Chemoattractant is Attenuated in Vivo

Overview
Journal Scand J Immunol
Date 2004 Mar 20
PMID 15030574
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Murine interferon-inducible T-cell alpha chemoattractant (I-TAC) is a potent non-ELR CXC chemokine that predominantly attracts activated T lymphocytes, binds to the receptor CXCR3 and is induced by interferon-gamma (IFN-gamma). We analysed I-TAC expression by reverse transcriptase-polymerase chain reaction during three different virus-infection models in mice, respiratory syncytial virus (RSV), influenza A and vaccinia virus western reserve (VV-WR). In the lungs from mice infected with RSV or influenza A viruses, peak expression of I-TAC coincided with peak viraemia. Surprisingly, there was no expression in the lungs of mice infected with vaccinia, unlike the elevated expression shown previously for other interferon-regulated chemokines, such as Crg2 and Mig. To further investigate the importance of this difference during vaccinia infection in mice, a recombinant virus encoding I-TAC (rVV I-TAC) was generated. Studies in C57BL/6 and Swiss nude mice showed that I-TAC expression caused increased mononuclear cell infiltration and significantly attenuated the VV. Infection of the footpads of naïve or already immune (with VV-WR) mice with either rVV I-TAC or VV-WR demonstrated that I-TAC expression reduced overall inflammation during infection and that this reduction was more pronounced in already immune mice. The data presented here show that I-TAC can have an important role during virus infections and that vaccinia has evolved ways to avoid inducing I-TAC expression.

Citing Articles

Systemic delivery of tannic acid-ferric-masked oncolytic adenovirus reprograms tumor microenvironment for improved therapeutic efficacy in glioblastoma.

Wang G, Mu M, Zhang Z, Chen Y, Yang N, Zhong K Cancer Gene Ther. 2024; 31(12):1804-1817.

PMID: 39385009 DOI: 10.1038/s41417-024-00839-8.


CXCL11-armed oncolytic adenoviruses enhance CAR-T cell therapeutic efficacy and reprogram tumor microenvironment in glioblastoma.

Wang G, Zhang Z, Zhong K, Wang Z, Yang N, Tang X Mol Ther. 2022; 31(1):134-153.

PMID: 36056553 PMC: 9840126. DOI: 10.1016/j.ymthe.2022.08.021.


CXCL11-Armed oncolytic poxvirus elicits potent antitumor immunity and shows enhanced therapeutic efficacy.

Liu Z, Ravindranathan R, Li J, Kalinski P, Guo Z, Bartlett D Oncoimmunology. 2016; 5(3):e1091554.

PMID: 27141352 PMC: 4839379. DOI: 10.1080/2162402X.2015.1091554.


Modulation of chemokines in the tumor microenvironment enhances oncolytic virotherapy for colorectal cancer.

Francis L, Guo Z, Liu Z, Ravindranathan R, Urban J, Sathaiah M Oncotarget. 2016; 7(16):22174-85.

PMID: 26956047 PMC: 5008353. DOI: 10.18632/oncotarget.7907.


Roles of retinoic acid-inducible gene-I-like receptors (RLRs), Toll-like receptor (TLR) 3 and 2'-5' oligoadenylate synthetase as viral recognition receptors on human mast cells in response to viral infection.

Tsutsui-Takeuchi M, Ushio H, Fukuda M, Yamada T, Niyonsaba F, Okumura K Immunol Res. 2015; 61(3):240-9.

PMID: 25550087 PMC: 4336646. DOI: 10.1007/s12026-014-8617-x.